Devices & Neurotechnology
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry

Sonova hearing-aid noise-reduction algorithm evaluation

Also known as: Hearing Aid with NR_4, Hearing Aid with NR_3, Hearing Aid with NR_2, Hearing Aid with standard Noise Reduction, Sonova2019_20, NCT04018911

Sonova AG

Primary source
Company
Sonova AG
Program Type
Software/Neurotech
Modality
Hearing Aid/Software
Stage
Interventional/NA
Status
Completed
Target Gene
Route / Mode
Hearing-aid sound-processing algorithm
Confidence
84%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-09
Geography
Switzerland
Population
adult, hearing-loss, hearing-aid-user, noise-reduction
Trial IDs
1
Mechanism

Randomized crossover evaluation of multiple hearing-aid noise-reduction sound-changing algorithms in CE-labelled Sonova brand hearing instruments.

Indications
Notes

Verified as a Sonova-sponsored study-level evaluation of noise-reduction algorithms. ClinicalTrials.gov labels the NR_4 arm as Drug, but the intervention description and study summary identify it as a hearing-aid sound-processing condition.

Evidence & Sources
1 structured sources
clinicaltrials
Supports: canonicalName, aliases, company, programType, stage, status, route, populationTags...
IDs: NCT04018911, Sonova2019_20
Open
Key Events
Clinical Trials (1)
Data Checks
study-level-not-standalone-productregistry-intervention-type-correctedno-posted-results-confirmed
Related Programs